Biotelemetry Inc. buy tamam
Start price
05.05.17
/
50%
€25.30
Target price
26.04.18
€35.18
Performance (%)
35.58%
End price
26.04.18
€34.30
Summary
This prediction ended on 26.04.18 with a price of €34.30. With a performance of 35.58% the BUY prediction by tamam was a big success. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biotelemetry Inc. | - | - | - | - |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by tamam for this prediction
In the thread Biotelemetry Inc. diskutieren
BioTelemetry: It's a buying opportunity as
the LifeWatch deal is still very much intact, and investors should consider a particularly tough comp BEAT had this quarter.
https://seekingalpha.com/article/4130067-biotelemetry-key-partnership-apples-heart-study-featuring-apples-watch
(Vom Mitglied beendet)


